← Eichor
Condition: Liver Steatosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Liver Steatosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)
Phase 2 · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT06599918Bicalutamide Therapy in Young Women With NAFLD and PCOS
Phase 1 · 1 location(s) · University of California, San Francisco · NCT05979389Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver Disease
Phase N/A · 1 location(s) · Assiut University · NCT04720560Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI
Phase N/A · 1 location(s) · German Diabetes Center · NCT05046483Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Diseas
Phase 2 · 1 location(s) · AB Biotics, SA · NCT07193927Comorbidities Resolution After MGB Surgery and Change in Body Composition
Phase N/A · 1 location(s) · All India Institute of Medical Sciences, Bhubaneswar · NCT06015620Fasted Exercise Training in Type 1 Diabetes (FED-T1D)
NA · 1 location(s) · University of Alberta · NCT06748963Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study
Phase N/A · 1 location(s) · Chongqing Medical University · NCT05974904Short-term Fat Overfeeding on the Effects of Liver Metabolism
NA · 1 location(s) · University of Oxford · NCT05962190A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 317 location(s) · 89bio, Inc. · NCT06419374Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China
Phase N/A · 1 location(s) · Wuxi Hisky Medical Technology Co Ltd · NCT05597709Surgical-imaging Research on Obesity (SIRO)
Phase N/A · 1 location(s) · The Affiliated Hospital of Xuzhou Medical University · NCT06268262Endoscopic Ultrasound Shear Wave for Liver Fibrosis in MASLD Patients: The RUMIPAMBA Trial
NA · 1 location(s) · Instituto Ecuatoriano de Enfermedades Digestivas · NCT06102980Positive Association of US-FLI With the Severity of CAD
Phase N/A · 1 location(s) · Chongqing Medical University · NCT06541132Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Non
NA · 3 location(s) · State Key Laboratory of Subhealth Intervention Technology · NCT07083336Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
Phase N/A · 1 location(s) · Methodist Health System · NCT06225193Implementing Food Referrals for Equity and Sustained Health
Phase 2 · 2 location(s) · University of California, San Diego · NCT06661538A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Ou
Phase 3 · 563 location(s) · Eli Lilly and Company · NCT07165028Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis Reversal
Phase N/A · 1 location(s) · Beijing Municipal Administration of Hospitals · NCT06707129Early Tracking of Childhood Health Determinants (ETCHED) Study
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT03481829Androgens and NAFLD Longitudinal Cohort Study
Phase N/A · 2 location(s) · University of California, San Francisco · NCT06124261Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease
Phase N/A · 2 location(s) · Brigham and Women's Hospital · NCT05728697InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Phase N/A · 1 location(s) · Dana-Farber Cancer Institute · NCT05463796Soluble Fibre Supplementation in NAFLD
Phase 2 · 1 location(s) · McMaster University · NCT05480696Expanded Studies on the SCAPIS Stockholm Reexamination Cohort
Phase N/A · 1 location(s) · Danderyd Hospital · NCT07476703Influence of Donor and Recipient Genetic Polymorphisms on Graft Steatosis After Liver Transplant
Phase N/A · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT07685353Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improv
Phase 2 · 2 location(s) · Li Lab,MD · NCT06798948Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
Phase 4 · 1 location(s) · The Cleveland Clinic · NCT07058155CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
Phase 1/Phase 2 · 1 location(s) · AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC · NCT07053488Prevalence of NAFLD in T1DM Patients
NA · 1 location(s) · Ziekenhuis Oost-Limburg · NCT06445361
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.